Holen Sie sich die Stockscreener-App
332.27
1.20%
3.93
Handel nachbörslich:
332.27
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
State of Wyoming Buys New Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Should Surging Vyjuvek-Driven Earnings Reshape How Krystal Biotech (KRYS) Investors View Its Risk Profile? - simplywall.st
Krystal Biotech (NASDAQ:KRYS) Upgraded to "Moderate Buy" at Royal Bank Of Canada - MarketBeat
Krystal Biotech (KRYS) Director Dino Rossi Sells 25,000 Shares - GuruFocus
Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common Stock - moomoo.com
Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares - Investing.com
Dino Rossi Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
RBC Capital Initiates Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $400 - moomoo.com
KRYS Looks 0.5% Undervalued on GF Value™ - GuruFocus
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says - marketscreener.com
KRYS Initiates Coverage by RBC Capital -- Rating Set to Outperfo - GuruFocus
Krystal Bio wins bullish view at RBC Capital Markets (KRYS) - Seeking Alpha
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More - Yahoo Finance
RBC Initiates Krystal Biotech at Outperform, With $400 Price Target - marketscreener.com
KRYSTAL BIOTECH, INC. : RBC INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $400 - Bitget
Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus - Sahm
Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK
Wolfe Research Maintains Krystal Biotech(KRYS.US) With Hold Rating - Moomoo
Trading Systems Reacting to (KRYS) Volatility - news.stocktradersdaily.com
Bank of America Corp DE Increases Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript - The Globe and Mail
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Renaissance Technologies LLC Has $2.48 Million Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run - Yahoo Finance
Krystal Biotech Inc (KRYS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Krystal Biotech (NASDAQ:KRYS) Upgraded at Chardan Capital - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance
California State Teachers Retirement System Has $6.76 Million Holdings in Krystal Biotech, Inc. $KRYS - marketbeat.com
Krystal Biotech, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:KRYS) 2026-08-05 - Seeking Alpha
Krystal Biotech (KRYS) After Its Q2 Beat Is The Valuation Case Still Intact - Sahm
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus - Yahoo Finance
Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $386 - Moomoo
Krystal Biotech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Brokers Issue Forecasts for Krystal Biotech FY2026 Earnings - MarketBeat
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: VYJUVEK Sales Surge 24% as ... By GuruFocus - Investing.com Canada
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: V - GuruFocus
Is Krystal Biotech (KRYS) Overvalued After Q2 Earnings Beat? EPS of $1.85 & Revenue of $119.2M; GF Score: 54/100 - GuruFocus
Why Is Krystal Biotech (KRYS) Dropping 7.0%? - AlphaStreet
Krystal Biotech stock falls 7% on revenue miss despite earnings beat - Investing.com South Africa
krystal biotech vyjuvek revenue rises 24 percent - grafa.com
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's What Happened - MarketBeat
Krystal Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Krystal Biotech Inc Earnings Call Transcript - GuruFocus
Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results - The Manila Times
Earnings Flash (KRYS) Krystal Biotech Posts Q2 EPS $1.79, vs. FactSet Est of $1.62 - marketscreener.com
Earnings Flash (KRYS) Krystal Biotech, Inc. Reports Q2 Revenue $119.2M, vs. FactSet Est of $120.9M - marketscreener.com
Krystal Biotech Reports Strong 2Q 2026 VYJUVEK Revenue Growth and Advances Multi-Program Genetic Medicines Pipeline - Quiver Quantitative
Krystal Biotech Q2 Earnings Beat Expectations - Intellectia AI
Krystal Biotech Q2 revenue rises on VYJUVEK strength - TradingView
Krystal Biotech 2Q 2026: Revenue $119.22M, EPS $1.79— 10-Q Summary - TradingView
Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales - Quiver Quantitative
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring A Promising 12.70% Upside - directorstalkinterviews.com
Healthcare of Ontario Pension Plan Trust Fund Purchases Shares of 4,664 Krystal Biotech, Inc. $KRYS - MarketBeat
Sei Investments Co. Has $12.03 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Drops 5.9% Amid Sector-Wide Selling - AlphaStreet
Krystal Biotech earnings in focus as Vyjuvek expansion accelerates By Investing.com - Investing.com Canada
Krystal Biotech slides as investors appear to reset ahead of earnings - Quiver Quantitative
Krystal Biotech (KRYS) Could Be 40% Overvalued As KB801 News Tests Its Price - Yahoo Finance
Krystal Biotech: Profitable, Self-Funding, And Loaded With Optionality (NASDAQ:KRYS) - Seeking Alpha
Krystal Biotech, Inc. $KRYS Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Krystal Biotech Inc (KRYS) Institutional Confidence - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Analysis: Biotechnology Pioneer with 12.40% Potential Upside - DirectorsTalk Interviews
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):